ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global BCG Vaccine Market Research Report 2026
Published Date: 2026-02-11
|
Report Code: QYRE-Auto-18D691
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global BCG Vaccine Market Insights and Forecast to 2028
BUY CHAPTERS

Global BCG Vaccine Market Research Report 2026

Code: QYRE-Auto-18D691
Report
2026-02-11
Pages:119
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Merck
China National Biotec
Serum Institute of India
Japan
Japan BCG Lab
AJ Vaccines
Biofarma
GreenSignal Bio Pharma
Biomed Lublin
Taj Pharmaceuticals
Ataulpho de Paiva
IVAC-Institute of Vaccines and Medical Biologicals
Queen Saovabha Mem. Inst
Microgen

BCG Vaccine Market Size

The global BCG Vaccine market was valued at US$ 82.61 million in 2025 and is anticipated to reach US$ 102 million by 2032, at a CAGR of 3.1% from 2026 to 2032.

BCG Vaccine Market

BCG Vaccine Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on BCG Vaccine competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
BCG Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and sometimes other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Guérin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80%of neonates and infants in countries where it is part of the national childhood immunization programme.
Market Drivers for BCG Vaccine:
High Prevalence of Tuberculosis (TB): The increasing incidence of TB, especially in densely populated and low-income countries, drives the demand for BCG vaccines to prevent the disease, particularly among children and healthcare workers.
Rising Awareness and Immunization Programs: Many governments and health organizations promote vaccination to control TB outbreaks, providing funding and infrastructure to distribute BCG vaccines widely, particularly in high-risk regions.
Growing Healthcare Investments in Emerging Markets: Expanding healthcare infrastructure and government spending in emerging economies have increased the availability and accessibility of the BCG vaccine.
Development of New TB Strains: The emergence of multidrug-resistant (MDR) and extensively drug-resistant (XDR) TB strains has highlighted the need for effective preventative measures like the BCG vaccine.
Market Challenges for BCG Vaccine:
Limited Efficacy in Adults: The BCG vaccine’s effectiveness diminishes in adults, as it primarily prevents severe forms of TB in children rather than pulmonary TB, which is common in adults.
Side Effects and Safety Concerns: For individuals with weakened immune systems, the live BCG vaccine may pose health risks, which restricts its use among certain populations.
Supply Chain Constraints: Manufacturing challenges and periodic shortages impact the availability of BCG vaccines in some regions, particularly low-income countries.
Competition from New Vaccines and Treatments: Research on new TB vaccines and alternative treatments could reduce the reliance on BCG, especially if future solutions offer broader protection across age groups.
This report delivers a comprehensive overview of the global BCG Vaccine market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding BCG Vaccine. The BCG Vaccine market size, estimates, and forecasts are provided in terms of sales volume (K Dose) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global BCG Vaccine market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist BCG Vaccine manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of BCG Vaccine Market Report

Report Metric Details
Report Name BCG Vaccine Market
Accounted market size in 2025 US$ 82.61 million
Forecasted market size in 2032 US$ 102 million
CAGR 3.1%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Immune Vaccine
  • Therapy Vaccine
by Application
  • Self-Procurement
  • UNICEF
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Merck, Japan BCG Lab, Serum Institute of India, AJ Vaccines, BioFarma, GreenSignal Bio Pharma, China National Biotec, Biomed Lublin, Taj Pharmaceuticals, Ataulpho de Paiva, IVAC – Institute of Vaccines and Medical Biologicals, Queen Saovabha Mem. Inst, Microgen
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for BCG Vaccine manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines BCG Vaccine sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is BCG Vaccine Market growing?

Ans: The BCG Vaccine Market witnessing a CAGR of 3.1% during the forecast period 2026-2032.

What is the BCG Vaccine Market size in 2032?

Ans: The BCG Vaccine Market size in 2032 will be US$ 102 million.

Who are the main players in the BCG Vaccine Market report?

Ans: The main players in the BCG Vaccine Market are Merck, Japan BCG Lab, Serum Institute of India, AJ Vaccines, BioFarma, GreenSignal Bio Pharma, China National Biotec, Biomed Lublin, Taj Pharmaceuticals, Ataulpho de Paiva, IVAC – Institute of Vaccines and Medical Biologicals, Queen Saovabha Mem. Inst, Microgen

What are the Application segmentation covered in the BCG Vaccine Market report?

Ans: The Applications covered in the BCG Vaccine Market report are Self-Procurement, UNICEF, Other

What are the Type segmentation covered in the BCG Vaccine Market report?

Ans: The Types covered in the BCG Vaccine Market report are Immune Vaccine, Therapy Vaccine

1 BCG Vaccine Market Overview
1.1 Product Definition
1.2 BCG Vaccine by Type
1.2.1 Global BCG Vaccine Market Value by Type: 2025 vs 2032
1.2.2 Immune Vaccine
1.2.3 Therapy Vaccine
1.3 BCG Vaccine by Application
1.3.1 Global BCG Vaccine Market Value by Application: 2025 vs 2032
1.3.2 Self-Procurement
1.3.3 UNICEF
1.3.4 Other
1.4 Global BCG Vaccine Market Size Estimates and Forecasts
1.4.1 Global BCG Vaccine Revenue 2021–2032
1.4.2 Global BCG Vaccine Sales 2021–2032
1.4.3 Global BCG Vaccine Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 BCG Vaccine Market Competition by Manufacturers
2.1 Global BCG Vaccine Sales Market Share by Manufacturers (2021–2026)
2.2 Global BCG Vaccine Revenue Market Share by Manufacturers (2021–2026)
2.3 Global BCG Vaccine Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of BCG Vaccine, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of BCG Vaccine, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of BCG Vaccine, Product Types and Applications
2.7 Global Key Manufacturers of BCG Vaccine, Date of Entry into the Industry
2.8 Global BCG Vaccine Market Competitive Situation and Trends
2.8.1 Global BCG Vaccine Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global BCG Vaccine Players Market Share by Revenue
2.8.3 Global BCG Vaccine Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global BCG Vaccine Market Scenario by Region
3.1 Global BCG Vaccine Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global BCG Vaccine Sales by Region: 2021–2032
3.2.1 Global BCG Vaccine Sales by Region: 2021–2026
3.2.2 Global BCG Vaccine Sales by Region: 2027–2032
3.3 Global BCG Vaccine Revenue by Region: 2021–2032
3.3.1 Global BCG Vaccine Revenue by Region: 2021–2026
3.3.2 Global BCG Vaccine Revenue by Region: 2027–2032
3.4 North America BCG Vaccine Market Facts & Figures by Country
3.4.1 North America BCG Vaccine Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America BCG Vaccine Sales by Country (2021–2032)
3.4.3 North America BCG Vaccine Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe BCG Vaccine Market Facts & Figures by Country
3.5.1 Europe BCG Vaccine Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe BCG Vaccine Sales by Country (2021–2032)
3.5.3 Europe BCG Vaccine Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific BCG Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific BCG Vaccine Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific BCG Vaccine Sales by Region (2021–2032)
3.6.3 Asia Pacific BCG Vaccine Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America BCG Vaccine Market Facts & Figures by Country
3.7.1 Latin America BCG Vaccine Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America BCG Vaccine Sales by Country (2021–2032)
3.7.3 Latin America BCG Vaccine Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa BCG Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa BCG Vaccine Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa BCG Vaccine Sales by Country (2021–2032)
3.8.3 Middle East and Africa BCG Vaccine Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global BCG Vaccine Sales by Type (2021–2032)
4.1.1 Global BCG Vaccine Sales by Type (2021–2026)
4.1.2 Global BCG Vaccine Sales by Type (2027–2032)
4.1.3 Global BCG Vaccine Sales Market Share by Type (2021–2032)
4.2 Global BCG Vaccine Revenue by Type (2021–2032)
4.2.1 Global BCG Vaccine Revenue by Type (2021–2026)
4.2.2 Global BCG Vaccine Revenue by Type (2027–2032)
4.2.3 Global BCG Vaccine Revenue Market Share by Type (2021–2032)
4.3 Global BCG Vaccine Price by Type (2021–2032)
5 Segment by Application
5.1 Global BCG Vaccine Sales by Application (2021–2032)
5.1.1 Global BCG Vaccine Sales by Application (2021–2026)
5.1.2 Global BCG Vaccine Sales by Application (2027–2032)
5.1.3 Global BCG Vaccine Sales Market Share by Application (2021–2032)
5.2 Global BCG Vaccine Revenue by Application (2021–2032)
5.2.1 Global BCG Vaccine Revenue by Application (2021–2026)
5.2.2 Global BCG Vaccine Revenue by Application (2027–2032)
5.2.3 Global BCG Vaccine Revenue Market Share by Application (2021–2032)
5.3 Global BCG Vaccine Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Company Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck BCG Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Merck BCG Vaccine Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Japan BCG Lab
6.2.1 Japan BCG Lab Company Information
6.2.2 Japan BCG Lab Description and Business Overview
6.2.3 Japan BCG Lab BCG Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Japan BCG Lab BCG Vaccine Product Portfolio
6.2.5 Japan BCG Lab Recent Developments/Updates
6.3 Serum Institute of India
6.3.1 Serum Institute of India Company Information
6.3.2 Serum Institute of India Description and Business Overview
6.3.3 Serum Institute of India BCG Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Serum Institute of India BCG Vaccine Product Portfolio
6.3.5 Serum Institute of India Recent Developments/Updates
6.4 AJ Vaccines
6.4.1 AJ Vaccines Company Information
6.4.2 AJ Vaccines Description and Business Overview
6.4.3 AJ Vaccines BCG Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 AJ Vaccines BCG Vaccine Product Portfolio
6.4.5 AJ Vaccines Recent Developments/Updates
6.5 BioFarma
6.5.1 BioFarma Company Information
6.5.2 BioFarma Description and Business Overview
6.5.3 BioFarma BCG Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 BioFarma BCG Vaccine Product Portfolio
6.5.5 BioFarma Recent Developments/Updates
6.6 GreenSignal Bio Pharma
6.6.1 GreenSignal Bio Pharma Company Information
6.6.2 GreenSignal Bio Pharma Description and Business Overview
6.6.3 GreenSignal Bio Pharma BCG Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 GreenSignal Bio Pharma BCG Vaccine Product Portfolio
6.6.5 GreenSignal Bio Pharma Recent Developments/Updates
6.7 China National Biotec
6.7.1 China National Biotec Company Information
6.7.2 China National Biotec Description and Business Overview
6.7.3 China National Biotec BCG Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 China National Biotec BCG Vaccine Product Portfolio
6.7.5 China National Biotec Recent Developments/Updates
6.8 Biomed Lublin
6.8.1 Biomed Lublin Company Information
6.8.2 Biomed Lublin Description and Business Overview
6.8.3 Biomed Lublin BCG Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Biomed Lublin BCG Vaccine Product Portfolio
6.8.5 Biomed Lublin Recent Developments/Updates
6.9 Taj Pharmaceuticals
6.9.1 Taj Pharmaceuticals Company Information
6.9.2 Taj Pharmaceuticals Description and Business Overview
6.9.3 Taj Pharmaceuticals BCG Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Taj Pharmaceuticals BCG Vaccine Product Portfolio
6.9.5 Taj Pharmaceuticals Recent Developments/Updates
6.10 Ataulpho de Paiva
6.10.1 Ataulpho de Paiva Company Information
6.10.2 Ataulpho de Paiva Description and Business Overview
6.10.3 Ataulpho de Paiva BCG Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Ataulpho de Paiva BCG Vaccine Product Portfolio
6.10.5 Ataulpho de Paiva Recent Developments/Updates
6.11 IVAC – Institute of Vaccines and Medical Biologicals
6.11.1 IVAC – Institute of Vaccines and Medical Biologicals Company Information
6.11.2 IVAC – Institute of Vaccines and Medical Biologicals Description and Business Overview
6.11.3 IVAC – Institute of Vaccines and Medical Biologicals BCG Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 IVAC – Institute of Vaccines and Medical Biologicals BCG Vaccine Product Portfolio
6.11.5 IVAC – Institute of Vaccines and Medical Biologicals Recent Developments/Updates
6.12 Queen Saovabha Mem. Inst
6.12.1 Queen Saovabha Mem. Inst Company Information
6.12.2 Queen Saovabha Mem. Inst Description and Business Overview
6.12.3 Queen Saovabha Mem. Inst BCG Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Queen Saovabha Mem. Inst BCG Vaccine Product Portfolio
6.12.5 Queen Saovabha Mem. Inst Recent Developments/Updates
6.13 Microgen
6.13.1 Microgen Company Information
6.13.2 Microgen Description and Business Overview
6.13.3 Microgen BCG Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Microgen BCG Vaccine Product Portfolio
6.13.5 Microgen Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 BCG Vaccine Industry Chain Analysis
7.2 BCG Vaccine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 BCG Vaccine Production Mode & Process Analysis
7.4 BCG Vaccine Sales and Marketing
7.4.1 BCG Vaccine Sales Channels
7.4.2 BCG Vaccine Distributors
7.5 BCG Vaccine Customer Analysis
8 BCG Vaccine Market Dynamics
8.1 BCG Vaccine Industry Trends
8.2 BCG Vaccine Market Drivers
8.3 BCG Vaccine Market Challenges
8.4 BCG Vaccine Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Merck
China National Biotec
Serum Institute of India
Japan
Japan BCG Lab
AJ Vaccines
Biofarma
GreenSignal Bio Pharma
Biomed Lublin
Taj Pharmaceuticals
Ataulpho de Paiva
IVAC-Institute of Vaccines and Medical Biologicals
Queen Saovabha Mem. Inst
Microgen
List of Tables
 Table 1. Global BCG Vaccine Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global BCG Vaccine Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global BCG Vaccine Market Competitive Situation by Manufacturers in 2025
 Table 4. Global BCG Vaccine Sales (K Dose) of Key Manufacturers (2021–2026)
 Table 5. Global BCG Vaccine Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global BCG Vaccine Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global BCG Vaccine Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market BCG Vaccine Average Price (US$/Dose) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of BCG Vaccine, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of BCG Vaccine, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of BCG Vaccine, Product Types and Applications
 Table 12. Global Key Manufacturers of BCG Vaccine, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global BCG Vaccine Companies by Tier (Tier 1, Tier 2, Tier 3), based on BCG Vaccine Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global BCG Vaccine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global BCG Vaccine Sales by Region (K Dose), 2021–2026
 Table 18. Global BCG Vaccine Sales Market Share by Region (2021–2026)
 Table 19. Global BCG Vaccine Sales by Region (K Dose), 2027–2032
 Table 20. Global BCG Vaccine Sales Market Share by Region (2027–2032)
 Table 21. Global BCG Vaccine Revenue by Region (US$ Million), 2021–2026
 Table 22. Global BCG Vaccine Revenue Market Share by Region (2021–2026)
 Table 23. Global BCG Vaccine Revenue by Region (US$ Million), 2027–2032
 Table 24. Global BCG Vaccine Revenue Market Share by Region (2027–2032)
 Table 25. North America BCG Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America BCG Vaccine Sales by Country (K Dose), 2021–2026
 Table 27. North America BCG Vaccine Sales by Country (K Dose), 2027–2032
 Table 28. North America BCG Vaccine Revenue by Country (US$ Million), 2021–2026
 Table 29. North America BCG Vaccine Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe BCG Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe BCG Vaccine Sales by Country (K Dose), 2021–2026
 Table 32. Europe BCG Vaccine Sales by Country (K Dose), 2027–2032
 Table 33. Europe BCG Vaccine Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe BCG Vaccine Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific BCG Vaccine Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific BCG Vaccine Sales by Region (K Dose), 2021–2026
 Table 37. Asia Pacific BCG Vaccine Sales by Region (K Dose), 2027–2032
 Table 38. Asia Pacific BCG Vaccine Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific BCG Vaccine Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America BCG Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America BCG Vaccine Sales by Country (K Dose), 2021–2026
 Table 42. Latin America BCG Vaccine Sales by Country (K Dose), 2027–2032
 Table 43. Latin America BCG Vaccine Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America BCG Vaccine Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa BCG Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa BCG Vaccine Sales by Country (K Dose), 2021–2026
 Table 47. Middle East and Africa BCG Vaccine Sales by Country (K Dose), 2027–2032
 Table 48. Middle East and Africa BCG Vaccine Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa BCG Vaccine Revenue by Country (US$ Million), 2027–2032
 Table 50. Global BCG Vaccine Sales (K Dose) by Type (2021–2026)
 Table 51. Global BCG Vaccine Sales (K Dose) by Type (2027–2032)
 Table 52. Global BCG Vaccine Sales Market Share by Type (2021–2026)
 Table 53. Global BCG Vaccine Sales Market Share by Type (2027–2032)
 Table 54. Global BCG Vaccine Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global BCG Vaccine Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global BCG Vaccine Revenue Market Share by Type (2021–2026)
 Table 57. Global BCG Vaccine Revenue Market Share by Type (2027–2032)
 Table 58. Global BCG Vaccine Price (US$/Dose) by Type (2021–2026)
 Table 59. Global BCG Vaccine Price (US$/Dose) by Type (2027–2032)
 Table 60. Global BCG Vaccine Sales (K Dose) by Application (2021–2026)
 Table 61. Global BCG Vaccine Sales (K Dose) by Application (2027–2032)
 Table 62. Global BCG Vaccine Sales Market Share by Application (2021–2026)
 Table 63. Global BCG Vaccine Sales Market Share by Application (2027–2032)
 Table 64. Global BCG Vaccine Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global BCG Vaccine Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global BCG Vaccine Revenue Market Share by Application (2021–2026)
 Table 67. Global BCG Vaccine Revenue Market Share by Application (2027–2032)
 Table 68. Global BCG Vaccine Price (US$/Dose) by Application (2021–2026)
 Table 69. Global BCG Vaccine Price (US$/Dose) by Application (2027–2032)
 Table 70. Merck Company Information
 Table 71. Merck Description and Business Overview
 Table 72. Merck BCG Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
 Table 73. Merck BCG Vaccine Product
 Table 74. Merck Recent Developments/Updates
 Table 75. Japan BCG Lab Company Information
 Table 76. Japan BCG Lab Description and Business Overview
 Table 77. Japan BCG Lab BCG Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
 Table 78. Japan BCG Lab BCG Vaccine Product
 Table 79. Japan BCG Lab Recent Developments/Updates
 Table 80. Serum Institute of India Company Information
 Table 81. Serum Institute of India Description and Business Overview
 Table 82. Serum Institute of India BCG Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
 Table 83. Serum Institute of India BCG Vaccine Product
 Table 84. Serum Institute of India Recent Developments/Updates
 Table 85. AJ Vaccines Company Information
 Table 86. AJ Vaccines Description and Business Overview
 Table 87. AJ Vaccines BCG Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
 Table 88. AJ Vaccines BCG Vaccine Product
 Table 89. AJ Vaccines Recent Developments/Updates
 Table 90. BioFarma Company Information
 Table 91. BioFarma Description and Business Overview
 Table 92. BioFarma BCG Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
 Table 93. BioFarma BCG Vaccine Product
 Table 94. BioFarma Recent Developments/Updates
 Table 95. GreenSignal Bio Pharma Company Information
 Table 96. GreenSignal Bio Pharma Description and Business Overview
 Table 97. GreenSignal Bio Pharma BCG Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
 Table 98. GreenSignal Bio Pharma BCG Vaccine Product
 Table 99. GreenSignal Bio Pharma Recent Developments/Updates
 Table 100. China National Biotec Company Information
 Table 101. China National Biotec Description and Business Overview
 Table 102. China National Biotec BCG Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
 Table 103. China National Biotec BCG Vaccine Product
 Table 104. China National Biotec Recent Developments/Updates
 Table 105. Biomed Lublin Company Information
 Table 106. Biomed Lublin Description and Business Overview
 Table 107. Biomed Lublin BCG Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
 Table 108. Biomed Lublin BCG Vaccine Product
 Table 109. Biomed Lublin Recent Developments/Updates
 Table 110. Taj Pharmaceuticals Company Information
 Table 111. Taj Pharmaceuticals Description and Business Overview
 Table 112. Taj Pharmaceuticals BCG Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
 Table 113. Taj Pharmaceuticals BCG Vaccine Product
 Table 114. Taj Pharmaceuticals Recent Developments/Updates
 Table 115. Ataulpho de Paiva Company Information
 Table 116. Ataulpho de Paiva Description and Business Overview
 Table 117. Ataulpho de Paiva BCG Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
 Table 118. Ataulpho de Paiva BCG Vaccine Product
 Table 119. Ataulpho de Paiva Recent Developments/Updates
 Table 120. IVAC – Institute of Vaccines and Medical Biologicals Company Information
 Table 121. IVAC – Institute of Vaccines and Medical Biologicals Description and Business Overview
 Table 122. IVAC – Institute of Vaccines and Medical Biologicals BCG Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
 Table 123. IVAC – Institute of Vaccines and Medical Biologicals BCG Vaccine Product
 Table 124. IVAC – Institute of Vaccines and Medical Biologicals Recent Developments/Updates
 Table 125. Queen Saovabha Mem. Inst Company Information
 Table 126. Queen Saovabha Mem. Inst Description and Business Overview
 Table 127. Queen Saovabha Mem. Inst BCG Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
 Table 128. Queen Saovabha Mem. Inst BCG Vaccine Product
 Table 129. Queen Saovabha Mem. Inst Recent Developments/Updates
 Table 130. Microgen Company Information
 Table 131. Microgen Description and Business Overview
 Table 132. Microgen BCG Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
 Table 133. Microgen BCG Vaccine Product
 Table 134. Microgen Recent Developments/Updates
 Table 135. Key Raw Materials Lists
 Table 136. Raw Materials Key Suppliers Lists
 Table 137. BCG Vaccine Distributors List
 Table 138. BCG Vaccine Customers List
 Table 139. BCG Vaccine Market Trends
 Table 140. BCG Vaccine Market Drivers
 Table 141. BCG Vaccine Market Challenges
 Table 142. BCG Vaccine Market Restraints
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. Product Picture of BCG Vaccine
 Figure 2. Global BCG Vaccine Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global BCG Vaccine Market Share by Type: 2025 & 2032
 Figure 4. Immune Vaccine Product Picture
 Figure 5. Therapy Vaccine Product Picture
 Figure 6. Global BCG Vaccine Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global BCG Vaccine Market Share by Application: 2025 & 2032
 Figure 8. Self-Procurement
 Figure 9. UNICEF
 Figure 10. Other
 Figure 11. Global BCG Vaccine Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 12. Global BCG Vaccine Market Size (US$ Million), 2021–2032
 Figure 13. Global BCG Vaccine Sales (K Dose), 2021–2032
 Figure 14. Global BCG Vaccine Average Price (US$/Dose), 2021–2032
 Figure 15. BCG Vaccine Report Years Considered
 Figure 16. BCG Vaccine Sales Share by Manufacturers in 2025
 Figure 17. Global BCG Vaccine Revenue Share by Manufacturers in 2025
 Figure 18. Top 5 and Top 10 Global BCG Vaccine Players: Market Share by Revenue in BCG Vaccine in 2025
 Figure 19. BCG Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 20. Global BCG Vaccine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 21. North America BCG Vaccine Sales Market Share by Country (2021–2032)
 Figure 22. North America BCG Vaccine Revenue Market Share by Country (2021–2032)
 Figure 23. U.S. BCG Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 24. Canada BCG Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Europe BCG Vaccine Sales Market Share by Country (2021–2032)
 Figure 26. Europe BCG Vaccine Revenue Market Share by Country (2021–2032)
 Figure 27. Germany BCG Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. France BCG Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. U.K. BCG Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Italy BCG Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Russia BCG Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Asia Pacific BCG Vaccine Sales Market Share by Region (2021–2032)
 Figure 33. Asia Pacific BCG Vaccine Revenue Market Share by Region (2021–2032)
 Figure 34. China BCG Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. Japan BCG Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. South Korea BCG Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. India BCG Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. Australia BCG Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Taiwan BCG Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Indonesia BCG Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Thailand BCG Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Malaysia BCG Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Philippines BCG Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Latin America BCG Vaccine Sales Market Share by Country (2021–2032)
 Figure 45. Latin America BCG Vaccine Revenue Market Share by Country (2021–2032)
 Figure 46. Mexico BCG Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Brazil BCG Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Argentina BCG Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Middle East and Africa BCG Vaccine Sales Market Share by Country (2021–2032)
 Figure 50. Middle East and Africa BCG Vaccine Revenue Market Share by Country (2021–2032)
 Figure 51. Turkey BCG Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Saudi Arabia BCG Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. U.A.E BCG Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 54. Global Sales Market Share of BCG Vaccine by Type (2021–2032)
 Figure 55. Global Revenue Market Share of BCG Vaccine by Type (2021–2032)
 Figure 56. Global BCG Vaccine Price (US$/Dose) by Type (2021–2032)
 Figure 57. Global Sales Market Share of BCG Vaccine by Application (2021–2032)
 Figure 58. Global Revenue Market Share of BCG Vaccine by Application (2021–2032)
 Figure 59. Global BCG Vaccine Price (US$/Dose) by Application (2021–2032)
 Figure 60. BCG Vaccine Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Global BCG Vaccination Market Research Report 2025
Global BCG and Tuberculosis Vaccine Market Research Report 2025
Global Tuberculosis Vaccination Market Research Report 2025
TB Vaccine Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
VPM1002 Tuberculosis BCG Based Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
BCG Tuberculosis TB Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Bacille Calmette Guerin Vaccine Market Research Report 2024
Tuberculosis Prevention and Treatment Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global BCG Vaccine for Tuberculosis TB Market Research Report 2025
Global TB Vaccines Market Insights Forecast to 2030
Global TB Disease Vaccine Market Research Report 2025
Global Bacillus Calmette Guerin Vaccine Market Research Report 2025
Global Tuberculosis Vaccines Market Research Report 2024
Global Therapeutic BCG Vaccines Market Insights Forecast to 2030
Global BCG Vaccine for Intradermal Injection Market Research Report 2024
Global Tuberculosis Vaccine for Vhildren Market Research Report 2024
Bacille Calmette Guérin Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Tuberculosis Vaccine Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Brucellosis Vaccines Market Research Report 2025
Disease Control and Prevention Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions